STOCK TITAN

Director at Controladora Vuela (NYSE: VLRS) exercises RSUs, receives new grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Controladora Vuela Compania de Aviacion director Monica Aspe Bernal exercised equity awards and received a new grant. On April 28, 2026, she exercised 106,461 Restricted Securities Units into the same number of Series A shares of common stock, increasing her direct holdings to 196,414 shares.

Separately, on April 24, 2026, she received a grant of 56,811 Restricted Securities Units, each representing a contingent right to one Series A share. Footnotes state one RSU grant made on April 28, 2025 vested on April 28, 2026, while the April 24, 2026 grant will vest on April 24, 2027.

Positive

  • None.

Negative

  • None.
Insider Aspe Bernal Monica
Role null
Type Security Shares Price Value
Exercise Restricted Securities Units (BoDIP) 106,461 $0.00 --
Exercise Series A shares of common stock 106,461 $0.00 --
Grant/Award Restricted Securities Units (BoDIP) 56,811 $0.00 --
Holdings After Transaction: Restricted Securities Units (BoDIP) — 0 shares (Direct, null); Series A shares of common stock — 196,414 shares (Direct, null)
Footnotes (1)
  1. The Restricted Securities Units ("RSUs") were granted on April 28, 2025 and vest on April 28, 2026. The RSUs have no expiration date. Each RSU represents a contingent right to receive on Series A share of common stock. The RSUs were granted on April 24, 2026 and will vest on April 24, 2027. The RSUs have no expiration date.
RSUs exercised 106,461 shares Restricted Securities Units converted to Series A shares on April 28, 2026
Shares held after exercise 196,414 shares Direct Series A share ownership following April 28, 2026 transactions
New RSU grant 56,811 units Restricted Securities Units granted on April 24, 2026
RSU-to-share ratio 1 RSU : 1 share Each RSU represents a contingent right to one Series A share
Exercise transactions 1 transaction, 106,461 shares Aggregate exercise activity reported in transaction summary
Restricted Securities Units financial
"The Restricted Securities Units ("RSUs") were granted on April 28, 2025"
Series A shares of common stock financial
"security_title": "Series A shares of common stock""
Exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Aspe Bernal Monica

(Last)(First)(Middle)
AV. ANTONIO DOVALI JAIME NO. 70
13 FL, TWR B, COLONIA ZEDEC SANTA FE

(Street)
MEXICO CITY01210

(City)(State)(Zip)

MEXICO

(Country)
2. Issuer Name and Ticker or Trading Symbol
Controladora Vuela Compania de Aviacion, S.A.B. de C.V. [ VLRS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Series A shares of common stock04/28/2026M(1)106,461A(3)196,414D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Securities Units (BoDIP)(2)04/24/2026A56,811 (3) (3)Series A shares of common stock56,811$0.0056,811D
Restricted Securities Units (BoDIP)(2)04/28/2026M106,461 (1) (1)Series A shares of common stock106,461$0.000D
Explanation of Responses:
1. The Restricted Securities Units ("RSUs") were granted on April 28, 2025 and vest on April 28, 2026. The RSUs have no expiration date.
2. Each RSU represents a contingent right to receive on Series A share of common stock.
3. The RSUs were granted on April 24, 2026 and will vest on April 24, 2027. The RSUs have no expiration date.
/s/ Isela Cervantes Rodriguez, as Attorney-in-Fact, for Monica Aspe Bernal04/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did VLRS director Monica Aspe Bernal report?

Monica Aspe Bernal reported an RSU exercise and a new RSU grant. She exercised 106,461 Restricted Securities Units into Series A shares on April 28, 2026, and separately received 56,811 new RSUs on April 24, 2026 as a compensation-related award.

How many VLRS shares does Monica Aspe Bernal hold after these transactions?

After the reported transactions, she directly holds 196,414 Series A shares. This figure reflects the 106,461 shares received from exercising Restricted Securities Units on April 28, 2026, combined with her prior holdings, as shown in the Form 4 data.

What are the details of the new RSU grant reported for VLRS?

The new grant consists of 56,811 Restricted Securities Units. According to the filing, these RSUs were granted on April 24, 2026, each represents a contingent right to receive one Series A share, and they will vest on April 24, 2027 with no expiration date.

What vesting schedules are disclosed for VLRS director RSU awards?

The filing describes two RSU vesting schedules. One RSU grant was made on April 28, 2025 and vested on April 28, 2026. A separate grant on April 24, 2026 will vest on April 24, 2027. Both sets of RSUs have no expiration date, per the footnotes.

Did the VLRS insider Form 4 show any open-market share purchases or sales?

No open-market purchases or sales are reported in this Form 4. All transactions involve compensation-related equity awards: the exercise or conversion of Restricted Securities Units into 106,461 Series A shares, and the grant of 56,811 new RSUs to the director.